Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis MyNeuroNews, 17 Sep 2020 Background: Glioblastoma (GBM) is the most aggressive type of primary malignant brain tumor.